Characterization of Lethal Zika Virus Infection in AG129 Mice

PLoS Neglected Tropical Diseases

Volumn 10, Issue 4, 2016, Pages

  Aliota, Matthew T ^a   Caine, Elizabeth A ^a   Walker, Emma C ^a   Larkin, Katrina E ^a   Camacho, Erwin ^a   Osorio, Jorge E ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; ALPHA BETA INTERFERON RECEPTOR; GAMMA INTERFERON RECEPTOR; INTERFERON RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPSY; CONCEPTUAL FRAMEWORK; CONTROLLED STUDY; FEMALE; HAPLORHINI; HISTOLOGY; INOCULATION; MICROSCOPY; MORPHOLOGICAL TRAIT; MORTALITY; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PREGNANCY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRULENCE; VIRUS; VIRUS LOAD; ZIKA VIRUS; ANIMAL; BRAIN; DEATH; DEFICIENCY; DISEASE MODEL; KNOCKOUT MOUSE; MUSCLE; PATHOLOGY; VIREMIA; VIROLOGY; ZIKA FEVER;

ANIMALS; BRAIN; DEATH; DISEASE MODELS, ANIMAL; MICE; MICE, KNOCKOUT; MUSCLES; RECEPTOR, INTERFERON ALPHA-BETA; RECEPTORS, INTERFERON; VIREMIA; ZIKA VIRUS INFECTION;

EID: 84964800603     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0004682     Document Type: Article

References (41)

1. Duffy MR, Chen T-H, Hancock WT, Powers AM, Kool JL, Lanciotti RS, et al. Zika virus outbreak on Yap Island, Federated States of Micronesia. N Engl J Med. 2009;360: 2536–2543. doi: 10.1056/NEJMoa080571519516034
2. Cao-Lormeau V-M, Roche C, Teissier A, Robin E, Berry A-L, Mallet H-P, et al. Zika virus, French polynesia, South pacific, 2013. Emerg Infect Dis. 2014;20: 1085–1086. doi: 10.3201/eid2006.14013824856001
3. Campos GS, Bandeira AC, Sardi SI, Zika Virus Outbreak, Bahia, Brazil. Emerg Infect Dis. 2015;21: 1885–1886. doi: 10.3201/eid2110.15084726401719
4. Musso D, Cao-Lormeau VM, Gubler DJ, Zika virus: following the path of dengue and chikungunya?Lancet Lond Engl. 2015;386: 243–244. doi: 10.1016/S0140-6736(15)61273-9
5. Dyer O, Zika virus spreads across Americas as concerns mount over birth defects. BMJ. 2015;351: h6983. doi: 10.1136/bmj.h698326698165
6. Mlakar J, Korva M, Tul N, Popović M, Poljšak-Prijatelj M, Mraz J, et al. Zika Virus Associated with Microcephaly. N Engl J Med. 2016;0: null. doi: 10.1056/NEJMoa1600651
7. Rapid risk assessment: Microcephaly in Brazil potentially linked to Zika virus epidemic. Stockholm: ECDC: European Centre for Disease Prevention and Control; 2015Nov.
8. Hayes EB, Zika virus outside Africa. Emerg Infect Dis. 2009;15: 1347–1350. doi: 10.3201/eid1509.09044219788800
9. Haddow AJ, Williams MC, Woodall JP, Simpson DI, Goma LK, TWELVE ISOLATIONS OF ZIKA VIRUS FROM AEDES (STEGOMYIA) AFRICANUS (THEOBALD) TAKEN IN AND ABOVE A UGANDA FOREST. Bull World Health Organ. 1964;31: 57–69. 14230895
10. McCrae AW, Kirya BG, Yellow fever and Zika virus epizootics and enzootics in Uganda. Trans R Soc Trop Med Hyg. 1982;76: 552–562. 6304948
11. Marchette NJ, Garcia R, Rudnick A, Isolation of Zika virus from Aedes aegypti mosquitoes in Malaysia. Am J Trop Med Hyg. 1969;18: 411–415. 4976739
12. Wong P-SJ, Li MI, Chong C-S, Ng L-C, Tan C-H, Aedes (Stegomyia) albopictus (Skuse): A Potential Vector of Zika Virus in Singapore. PLoS Negl Trop Dis. 2013;7: e2348. doi: 10.1371/journal.pntd.000234823936579
13. Grard G, Caron M, Mombo IM, Nkoghe D, Mboui Ondo S, Jiolle D, et al. Zika virus in Gabon (Central Africa)—2007: a new threat from Aedes albopictus?PLoS Negl Trop Dis. 2014;8: e2681. doi: 10.1371/journal.pntd.000268124516683
14. Dick GWA, Zika virus. II. Pathogenicity and physical properties. Trans R Soc Trop Med Hyg. 1952;46: 521–534. 12995441
15. Way JH, Bowen ET, Platt GS, Comparative studies of some African arboviruses in cell culture and in mice. J Gen Virol. 1976;30: 123–130. doi: 10.1099/0022-1317-30-1-1231245842
16. Weinbren MP, Williams MC, Zika virus: further isolations in the Zika area, and some studies on the strains isolated. Trans R Soc Trop Med Hyg. 1958;52: 263–268. 13556872
17. Bell TM, Field EJ, Narang HK, Zika virus infection of the central nervous system of mice. Arch Für Gesamte Virusforsch. 1971;35: 183–193.
18. Hamel R, Dejarnac O, Wichit S, Ekchariyawat P, Neyret A, Luplertlop N, et al. Biology of Zika Virus Infection in Human Skin Cells. J Virol. 2015;89: 8880–8896. doi: 10.1128/JVI.00354-1526085147
19. Diamond MS, Shrestha B, Mehlhop E, Sitati E, Engle M, Innate and adaptive immune responses determine protection against disseminated infection by West Nile encephalitis virus. Viral Immunol. 2003;16: 259–278. doi: 10.1089/08828240332239608214583143
20. Keller BC, Fredericksen BL, Samuel MA, Mock RE, Mason PW, Diamond MS, et al. Resistance to alpha/beta interferon is a determinant of West Nile virus replication fitness and virulence. J Virol. 2006;80: 9424–9434. doi: 10.1128/JVI.00768-0616973548
21. Lobigs M, Müllbacher A, Wang Y, Pavy M, Lee E, Role of type I and type II interferon responses in recovery from infection with an encephalitic flavivirus. J Gen Virol. 2003;84: 567–572. doi: 10.1099/vir.0.18654-012604807
22. Diamond MS, Harris E, Interferon inhibits dengue virus infection by preventing translation of viral RNA through a PKR-independent mechanism. Virology. 2001;289: 297–311. doi: 10.1006/viro.2001.111411689052
23. Shresta S, Kyle JL, Snider HM, Basavapatna M, Beatty PR, Harris E, Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical. J Virol. 2004;78: 2701–2710. 14990690
24. Lanciotti RS, Kosoy OL, Laven JJ, Velez JO, Lambert AJ, Johnson AJ, et al. Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis. 2008;14: 1232–1239. doi: 10.3201/eid1408.08028718680646
25. Kyle JL, Beatty PR, Harris E, Dengue virus infects macrophages and dendritic cells in a mouse model of infection. J Infect Dis. 2007;195: 1808–1817. doi: 10.1086/51800717492597
26. Bourne N, Scholle F, Silva MC, Rossi SL, Dewsbury N, Judy B, et al. Early production of type I interferon during West Nile virus infection: role for lymphoid tissues in IRF3-independent interferon production. J Virol. 2007;81: 9100–9108. doi: 10.1128/JVI.00316-0717567689
27. Dick GWA, Kitchen SF, Haddow AJ, Zika virus. I. Isolations and serological specificity. Trans R Soc Trop Med Hyg. 1952;46: 509–520. 12995440
28. Bogoch II, Brady OJ, Kraemer MUG, German M, Creatore MI, Kulkarni MA, et al. Anticipating the international spread of Zika virus from Brazil. Lancet Lond Engl. 2016;387: 335–336. doi: 10.1016/S0140-6736(16)00080-5
29. Yu C-Y, Chang T-H, Liang J-J, Chiang R-L, Lee Y-L, Liao C-L, et al. Dengue virus targets the adaptor protein MITA to subvert host innate immunity. PLoS Pathog. 2012;8: e1002780. doi: 10.1371/journal.ppat.100278022761576
30. Aguirre S, Maestre AM, Pagni S, Patel JR, Savage T, Gutman D, et al. DENV inhibits type I IFN production in infected cells by cleaving human STING. PLoS Pathog. 2012;8: e1002934. doi: 10.1371/journal.ppat.100293423055924
31. Ashour J, Morrison J, Laurent-Rolle M, Belicha-Villanueva A, Plumlee CR, Bernal-Rubio D, et al. Mouse STAT2 restricts early dengue virus replication. Cell Host Microbe. 2010;8: 410–421. doi: 10.1016/j.chom.2010.10.00721075352
32. Kyle JL, Balsitis SJ, Zhang L, Beatty PR, Harris E, Antibodies play a greater role than immune cells in heterologous protection against secondary dengue virus infection in a mouse model. Virology. 2008;380: 296–303. doi: 10.1016/j.virol.2008.08.00818774583
33. Shresta S, Sharar KL, Prigozhin DM, Beatty PR, Harris E, Murine model for dengue virus-induced lethal disease with increased vascular permeability. J Virol. 2006;80: 10208–10217. doi: 10.1128/JVI.00062-0617005698
34. Balsitis SJ, Coloma J, Castro G, Alava A, Flores D, McKerrow JH, et al. Tropism of dengue virus in mice and humans defined by viral nonstructural protein 3-specific immunostaining. Am J Trop Med Hyg. 2009;80: 416–424. 19270292
35. Balsitis SJ, Williams KL, Lachica R, Flores D, Kyle JL, Mehlhop E, et al. Lethal antibody enhancement of dengue disease in mice is prevented by Fc modification. PLoS Pathog. 2010;6: e1000790. doi: 10.1371/journal.ppat.100079020168989
36. Yauch LE, Zellweger RM, Kotturi MF, Qutubuddin A, Sidney J, Peters B, et al. A protective role for dengue virus-specific CD8+ T cells. J Immunol Baltim Md 1950. 2009;182: 4865–4873. doi: 10.4049/jimmunol.0801974
37. Yauch LE, Prestwood TR, May MM, Morar MM, Zellweger RM, Peters B, et al. CD4+ T cells are not required for the induction of dengue virus-specific CD8+ T cell or antibody responses but contribute to protection after vaccination. J Immunol Baltim Md 1950. 2010;185: 5405–5416. doi: 10.4049/jimmunol.1001709
38. Zompi S, Santich BH, Beatty PR, Harris E, Protection from secondary dengue virus infection in a mouse model reveals the role of serotype cross-reactive B and T cells. J Immunol Baltim Md 1950. 2012;188: 404–416. doi: 10.4049/jimmunol.1102124
39. Fuchs J, Chu H, O’Day P, Pyles R, Bourne N, Das SC, et al. Investigating the efficacy of monovalent and tetravalent dengue vaccine formulations against DENV-4 challenge in AG129 mice. Vaccine. 2014; doi: 10.1016/j.vaccine.2014.08.087
40. Caine EA, Fuchs J, Das SC, Partidos CD, Osorio JE, Efficacy of a Trivalent Hand, Foot, and Mouth Disease Vaccine against Enterovirus 71 and Coxsackieviruses A16 and A6 in Mice. Viruses. 2015;7: 5919–5932. doi: 10.3390/v711291626593938
41. Partidos CD, Weger J, Brewoo J, Seymour R, Borland EM, Ledermann JP, et al. Probing the attenuation and protective efficacy of a candidate chikungunya virus vaccine in mice with compromised interferon (IFN) signaling. Vaccine. 2011;29: 3067–3073. doi: 10.1016/j.vaccine.2011.01.07621300099